| Financial Year |
March 31 2023 |
| Monetary Funds |
513,339,139.85 |
| Held-for-trading Financial Assets |
1,323,260,217.20 |
| Notes Receivable |
23,025,973.22 |
| Accounts Receivable |
862,672,274.52 |
| Advances to Suppliers |
7,916,414.00 |
| Other Receivables |
2,412,031.73 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
440,686,689.82 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
589,061.27 |
| Total Current Assets |
3,368,825,105.19 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
97,760,997.15 |
| Fixed Assetes |
109,107,476.90 |
| Under-construction Projects |
151,582,751.00 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
41,122,908.21 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
495,503.45 |
| Deferred Income Tax Assets |
37,975,843.70 |
| Other Non-Current Assets |
65,492,861.69 |
| Sub-Total of Non-Current Assets |
682,996,884.98 |
| Total Assets |
4,051,821,990.17 |
| Short-Term Loans |
89,800,958.12 |
| Trading Financial liabilities |
-- |
| Notes Payable |
41,803,968.27 |
| Accounts Payable |
122,669,395.56 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
3,313,127.63 |
| Taxes Payable |
26,863,946.20 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
2,776,534.18 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
19,231,931.24 |
| Sub-Total of Current Liabilities |
426,309,345.73 |
| Long-term Loans |
35,046,666.67 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
1,422,038.53 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
38,598,059.47 |
| Total Liabilities |
464,907,405.20 |
| Paid-In Capital(Or Share Stock) |
100,000,000.00 |
| Capital Surplus |
2,208,308,402.53 |
| Surplus Reserve |
50,000,000.00 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,228,606,182.44 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,586,914,584.97 |
| Owner's Equity（Stockholder's Equity） |
3,586,914,584.97 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,051,821,990.17 |
